Xinhai Ye1, Peng Zhang2, Shaobo Xue3, Yipin Xu1, Jian Tan1, Guangpeng Liu4. 1. Department of Plastic and Reconstructive Surgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, PR China. 2. Department of Orthopedic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, PR China. 3. The Central Laboratory of Shanghai Tenth People's Hospital, Tongji University, Shanghai, PR China. 4. Department of Plastic and Reconstructive Surgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, PR China. Electronic address: guangpengliu@163.com.
Abstract
BACKGROUND AIMS: Osteoporosis (OP) is characterized by a reduction in bone quality, which is associated with inadequacies in bone marrow mesenchymal stromal cells (BMSCs). As an alternative cell source to BMSCs, adipose-derived stem cells (ASCs) have been investigated for bone repair because of their osteogenic potential and self-renewal capability. Nevertheless, whether autologous ASCs can be used to promote bone regeneration under osteoporotic conditions has not been elucidated. METHODS: The OP rabbit model was established by means of bilateral ovariectomy (OVX). Both BMSCs and ASCs were harvested from OVX rabbits and expanded in vitro. The effects of osteogenic-induced ASCs on the in vitro adipogenic and osteogenic capabilities of BMSCs were evaluated. Autologous ASCs were then encapsulated by calcium alginate gel and transplanted into the distal femurs of OVX rabbits (n = 12). Hydrogel without loading cells was injected into the contralateral femurs as a control. Animals were killed for investigation at 12 weeks after transplantation. RESULTS: Osteogenic-induced ASCs were able to promote osteogenesis and inhibit adipogenesis of osteoporotic BMSCs through activation of the bone morphogenetic protein 2/bone morphogenetic protein receptor type IB signal pathway. Local bone mineral density began to increase at 8 weeks after ASC transplantation (P < 0.05). At 12 weeks, micro-computed tomography and histological evaluation revealed more new bone formation in the cell-treated femurs than in the control group (P < 0.05). CONCLUSIONS: This study demonstrated that ASCs could stimulate proliferation and osteogenic differentiation of BMSCs in vitro and enhance bone regeneration in vivo, which suggests that autologous osteogenic-induced ASCs might be useful to alleviate OP temporally.
BACKGROUND AIMS: Osteoporosis (OP) is characterized by a reduction in bone quality, which is associated with inadequacies in bone marrow mesenchymal stromal cells (BMSCs). As an alternative cell source to BMSCs, adipose-derived stem cells (ASCs) have been investigated for bone repair because of their osteogenic potential and self-renewal capability. Nevertheless, whether autologous ASCs can be used to promote bone regeneration under osteoporotic conditions has not been elucidated. METHODS: The OP rabbit model was established by means of bilateral ovariectomy (OVX). Both BMSCs and ASCs were harvested from OVX rabbits and expanded in vitro. The effects of osteogenic-induced ASCs on the in vitro adipogenic and osteogenic capabilities of BMSCs were evaluated. Autologous ASCs were then encapsulated by calcium alginate gel and transplanted into the distal femurs of OVX rabbits (n = 12). Hydrogel without loading cells was injected into the contralateral femurs as a control. Animals were killed for investigation at 12 weeks after transplantation. RESULTS: Osteogenic-induced ASCs were able to promote osteogenesis and inhibit adipogenesis of osteoporotic BMSCs through activation of the bone morphogenetic protein 2/bone morphogenetic protein receptor type IB signal pathway. Local bone mineral density began to increase at 8 weeks after ASC transplantation (P < 0.05). At 12 weeks, micro-computed tomography and histological evaluation revealed more new bone formation in the cell-treated femurs than in the control group (P < 0.05). CONCLUSIONS: This study demonstrated that ASCs could stimulate proliferation and osteogenic differentiation of BMSCs in vitro and enhance bone regeneration in vivo, which suggests that autologous osteogenic-induced ASCs might be useful to alleviate OP temporally.
Authors: Nathan Robert Wanderman; Cindy Mallet; Hugo Giambini; Nirong Bao; Chunfeng Zhao; Kai-Nan An; Brett A Freedman; Ahmad Nassr Journal: Asian Spine J Date: 2018-02-07
Authors: Chen-Xi Zheng; Bing-Dong Sui; Nu Liu; Cheng-Hu Hu; Tao He; Xin-Yi Zhang; Pan Zhao; Ji Chen; Kun Xuan; Yan Jin Journal: Sci Rep Date: 2018-03-26 Impact factor: 4.379